OxiStat Plus Presentation [ ~ 9422kb ]

Transcription

OxiStat Plus Presentation [ ~ 9422kb ]
\ Nowadays population +65 is 506million
\ 2008 – 2020: world population increase by 14%
ƒ + 35 years increase 26%
ƒ + 65 years increase 43%
\ Elderly population mostly in developed countries
OXIDATIVE STRESS
Antioxidants
O2 Free Radicals
Oxidative stress imbalance leads to premature aging.
BioPower Labs:
\ clinical analysis service provider
\ anti-aging personalized medicine analysis
C:\Users\Renata Blatt\Desk top\Fotolia_3862041_X S .j p g
+
[ 1st stage ]
+
[ 2nd stage ]
Oxistat Plus Report – Oxidative Stress Status
Name
Age
Gender
Weight
Height
John Smith
38
Male
80 Kg
1,75 m
Analyzed parameters
Results
Reference Values
Track Record
Observations
Beta‐galactosidase
79
*
‐
Early senescence signs
GSH/GSSG
30
41‐79µg/l
‐
Not depleted
Gamma‐
glutamylcysteine
SOD‐1
13
12‐43 U/l
‐
‐
55
14‐36 U/l
‐
‐
Catalase
60
9‐52 U/l
‐
‐
NADH dehydrogenase
125
38‐126 U/l
‐
‐
Cytochrome oxidase
42
14‐36 U/l
‐
‐
p53
80
*
‐
‐
Oxi‐LDL
1781
1370±427 nmol/L
‐
‐
Total ROS
325
*
‐
‐
*age dependent (see appendix)
Healthy
Unhealthy
Oxidative Stress Scale
Low
5
5
Medium
High
Value corresponding to a patient with decreased antioxidant defenses due to genetic
predisposition and/or lifestyle. This value may be improved with dietary changes and supplement
intake.
\ Market size: 985k units - 250 M€ (2007)
\ Rate of growth: 20% per year
525k
units
79k
units
151k
units
SOURCES: GENOVA DIAGNOSTICS, INTERLEUKIN, A4M, SBME,.
USA
\ Genelex
\ Interleukin
Genetic
Analysis Labs
\ Integrative Genomics
BIOCHEMICAL
TESTING
\ Sciona
USA and Europe
\ Genova Diagnostics
Europe
\ Genosolutions
CUSTOMERS (PRIVATE PRACTICE):
• Cellulemblock
• Porto Nutrition Clinic
• Persona
• Corporation Dermoestética
•…
Innovator
First Mover
\ Innovator » new technology / new type of diagnostic results.
\ First Movers » adding value in the anti-aging market.
Private Clinics
Upper Middle Class
Hypochondri
ac
BioPower Labs
Hospitals*
Chronical*
Diseases
Club Medical Department
Competition Athletes
*Health Plan Program
End Consumer
MEDICAL AESTHETIC CLINICS
» medical staff«
endocrinologist
nutritionists
dermatologist
HOSPITALS
SPORT MEDICAL DEPARTMENTS
CRO
OTHER PLATFORM APPLICATIONS
Ex: Corporation Dermoestetica;
CelullemBlock; Persona
Entry Market
Expansion Market
END
CONSUME
R
* Medical Aesthetic Clinics:
\ Number of clinics: ~6500 (Europe; North America; Brazil)
SELLING FEATURES:
•Unique measurement tool
• Easy and simple measurement scale
to use and read
•Personalized medicine tool
1 week
Client & Physicians
BioPower KIT:
Antioxidan
Antioxidan
t
t
SAMPLES
SAMPLES
\ Commercialization strategy: mainly through our intermediates through the
establishment of partnerships in the area of clinical and aesthetics players .
\ Brochure may be customized to indicate recommended treatments.
PATENT
Oxistat Plus
Year
1
Year
2
Year
3
Year
4
Year
5
Year
6
OXISTAT
Clinical
Testing
Scale
Set-up
OXISTAT PLUS
Expansion Market
500 k€ investment
2 M€ investment
Year
7
Year
8
Scientific & Advisory
Board
Oxista
t
Plus
\ Funding: 2,5 Million Euros, divided into 2 rounds
\ Payback: 4 years
by
Technologist
9Catarina Gonçalves
MBA’s
9 António Fernandes
9 Catarina Maia
9 Renata Blatt
Advisor
9 Eduardo
Teixeira
de Sousa